Background
Antibiotics exert their antimicrobial effect by destroying or slowing down the growth of bacteria, and can be categorized into different groups based on different mechanisms of action and chemical structures. Currently the use of antibiotics is increasing dramatically every year, and the misuse of antibiotics has led to the emergence of antibiotic-resistant genes, which can also spread horizontally to other bacteria, seriously affecting the therapeutic effect of antibiotics. One of the most commonly used antibiotics is tetracycline, first isolated in Streptomyces, which has a broad-spectrum antibacterial activity based on the antibacterial principle of inhibiting the ability of bacteria to synthesize proteins by attaching to the 30S ribosomal subunit of the bacteria. However, the misuse of tetracyclines in human clinical care and animal husbandry has become a major threat to the environment and human health, and tetracycline residues have been detected in various environmental conditions, including soil, surface water and marine environments, which have a negative impact on ecosystems and can accumulate along the food chain, affecting microbial growth and metabolism as well as the microbial community structure of ecosystems, further contributing to the development of antibiotic resistance. In addition to drug resistance, tetracycline residues are toxic, and tetracycline also poses a threat to drinking and irrigation water and destroys the microflora in the human gut. It is therefore important to develop efficient and economical treatment technologies to degrade tetracycline residues in the environment.
The most common cause of tetracycline contamination is its stability and low metabolism in humans and animals, where about 75% of the antibiotic is excreted, in addition to the frequent use of tetracycline as a growth promoter in agriculture is one of the causes of tetracycline contamination of the aquatic and acoustic environment. Tetracycline inhibited the growth of different algae, and the inhibitory effect increased with the concentration, when the concentration was 30 mg/L, the growth inhibition rate of mixed algae was 94%. Tetracycline also affects the abundance and species richness of planktonic organisms, which recover their abundance and species richness after exposure to tetracycline ceases. Elevated tetracycline concentrations also reduce water clarity and dissolved oxygen levels. Tetracycline contamination affects fish embryonic development and gut microbiota, alters fish behavior, and causes oxidative stress. Bacteria in aquatic environments are resistant to tetracyclines, and these resistance genes are often encoded in plasmids and transposons that can be passed on across species, leading to rapid spread of resistance among aquatic microbial populations and eventual transfer to human pathogens. These phenomena can further hinder available antibiotic treatments and increase the incidence of serious infectious diseases.
Degradation of tetracyclines can be categorized into non-biological and biological methods, as well as a combination of both. Common abiotic degradations are hydrolysis, adsorption, electrochemical, and photocatalytic oxidation, while biological degradation uses pure cultures of fungi and bacteria, precipitation, and sludge. A combination of the two can also be used to degrade tetracyclines using a combination of processes such as ozone and activated sludge, membrane bioreactor (MBR) with ozone, photocatalysis and biodegradation. The combined process of biochemical treatment and constructed wetlands (CWs) can further treat the low concentration of tetracycline in the effluent of wastewater treatment plants. Tetracycline in the influent can be removed by biodegradation, photolysis, hydrolysis, substrate adsorption, plant uptake and biological coupling, and the treatment effect is affected by the seasons, hydraulic loads, light intensities, plant species and other factors.
Figure 1. The fate of tetracycline and nutrients during biochemical treatment process coupled with an advanced treatment system
(Source: Shao S, et al. 2020)
References
- 1. Shao S, et al. Microbial degradation of tetracycline in the aquatic environment: a review. Crit Rev Biotechnol. 2020 Nov;40(7):1010-1018.
- 2. Amangelsin Y, et al. The Impact of Tetracycline Pollution on the Aquatic Environment and Removal Strategies. Antibiotics (Basel). 2023 Feb 23;12(3):440.
References
Third-Generation Cephalosporin- and Tetracycline-ResistantEscherichia coliand Antimicrobial Resistance Genes from Metagenomes of Mink Feces and Feed
FOODBORNE PATHOGENS AND DISEASE
Authors: Agga, Getahun E.; Silva, Philip J.; Martin, Randal S.
Abstract
American mink (Neovison vison) is a significant source of global fur production. Except for a few studies from Denmark and Canada reporting antimicrobial resistance in bacteria isolated from clinical cases, studies from the general mink population are scarce and absent in the United States. Mink feces (n = 42) and feed (n = 8) samples obtained from a mink farm were cultured for the enumeration and detection of tetracycline-resistant (TET (R))- and third-generation cephalosporin-resistant (TGC (R))-Escherichia coli. Isolates were characterized phenotypically for their resistance to other antibiotics and genotypically for resistance genes. TET (R) E. coliwere detected from 98% of feces samples (mean concentration = 6 log(10)) and from 100% of feed samples (mean concentration = 3.2 logs). Among TET (R) E. coliisolates, 44% (n = 41) of fecal- and 50% (n = 8) of feed isolates were multidrug resistant (MDR; resistance to >= 3 antimicrobial classes), and 96% (n = 49) of TET (R) isolates were positive fortet(A) and/ortet(B). TGC (R) E. coliwere detected from 95% of feces and 75% of feed samples with 78% (n = 40) of fecal isolates, and all six of the feed isolates were MDR. Nearly two-thirds (65%) of the TGC (R) E. coliisolates (n = 46) were positive forbla(CMY-2); the remaining 35% were positive forbla(CTX-M,)with thebla(CTX-M-14)being the predominant (75%,n = 16) variant detected. Metagenomic DNA was extracted directly from feces and feed samples, and it was tested for 84 antimicrobial resistance genes by using quantitative polymerase chain reaction (PCR) array; selected genes were also quantified by droplet digital PCR. The genes detected from the fecal samples belonged mainly to five antimicrobial classes: macrolide-lincosamide-streptogramin B (MLSB; 100% prevalence), TETs (88.1%), beta-lactams (71.4%), aminoglycosides (66.7%), and fluoroquinolones (47.6%). beta-Lactam, MLSB, and TET resistance genes were also detected from feed samples. Our study serves as a baseline for further studies and to streamline antimicrobial use in mink production in accordance with current regulations as in food animals.
Pharmacokinetics of doxycycline after oral administration of multiple doses in dogs
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS
Authors: De Lucas, Jose Julio; Rodriguez, Casilda; San Andres, Maria Dolores; Sainz, Angel; Villaescusa, Alejandra; Garcia-Sancho, Mercedes; Rodriguez-Franco, Fernando; San Andres, Manuel I.
Abstract
The aim of this study was to determine the pharmacokinetic parameters of doxycycline in dogs and assess the efficacy of an oral drug dosage regimen of 10 mg/kg daily for 28 days through Pharmacokinetic/Pharmacodynamic (PK/PD) target analysis based on Monte Carlo simulation, using previously published data for the zoonotic pathogen Staphylococcus pseudintermedius. After a multiple-dosage regimen, the accumulation index was 1.88 +/- 0.82. The Cmax(ss) and Cmin(ss) values were 5.18 +/- 1.81 mu g/ml and 1.91 +/- 1.35 mu g/ml, respectively. There were statistically significant differences for Cmax, Cmin at 24 hr, MRTt, AUCt and AUC infinity between days 1 and 28. The Cmin(ss) value was over the MIC of the principal pathogens, and Cmax(ss) was higher than the resistance values (>2 mu g/ml). For AUC/MIC indices of 12, 25 and 40, the cumulative fraction responses (CFR) were 94.01%, 69.55% and 60.86%, respectively; for an MIC value of 2 mu g/ml, the corresponding probability of target attainment (PTA) was 99.94%, 84.78% and 45.16%, respectively. Doxycycline was used against numerous localized infections in different organs and tissues. For the strains with MIC < 1 mu g/mL, PTA was close to 100%, even for the most demanding ones, specifically 94.98% for an index of 40% and 99.9% for an index of 25.